ArmoLIPID PLUS tablets

ArmoLIPID PLUS is a well-known dietary supplement used for managing cholesterol and supporting cardiovascular health. It was originally developed by the Italian pharmaceutical company Rottapharm Madaus.

Following a series of major industry acquisitions, the brand became part of the Swedish pharmaceutical giant Mylan, which subsequently merged with Pfizer's Upjohn division to form Viatris. Consequently, the brand is now owned by Viatris, a global healthcare leader headquartered in the United States. Despite these international ownership transitions, the product continues to be manufactured primarily in Italy, maintaining its heritage of quality in the nutraceutical sector.